LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination

Kelly M Hinkle1, Mei Yue, Bahareh Behrouz

  • 1Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA.

Insights

Loss of LRRK2 function in mice did not impair dopamine systems but caused behavioral changes and kidney degeneration. This study investigates LRRK2

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Mutations in the Leucine-rich repeat kinase 2 (LRRK2) gene are a leading cause of genetic Parkinson's disease.
  • The precise pathogenic mechanisms of LRRK2 mutations remain unclear, but suggested roles include neuronal polarity, neurotransmission, and protein degradation.

Purpose of the Study:

  • To investigate the in vivo function of LRRK2 by creating and analyzing mice lacking exon 41, which encodes the kinase domain's activation hinge.
  • To comprehensively assess the impact of LRRK2 loss on the dopaminergic system, behavior, and organ health up to 20 months of age.

Main Methods:

  • Generation of LRRK2 knockout mice lacking exon 41.
  • Evaluation of dopamine storage, release, uptake, and synthesis.
  • Behavioral testing including open-field and rotarod tests.
  • Analysis of dendritic spines, neurogenesis, and kidney pathology.

Main Results:

  • The dopaminergic system in LRRK2 knockout mice showed no functional impairment.
  • LRRK2 knockout mice exhibited altered exploratory activity and improved performance on the accelerated rotarod test.
  • Loss of LRRK2 led to kidney degeneration with enhanced autophagic activity and autofluorescent material accumulation.

Conclusions:

  • Loss of LRRK2 does not compromise the dopaminergic system but affects motor behavior and causes kidney pathology.
  • The study highlights a role for LRRK2 in kidney homeostasis and suggests potential therapeutic targets for Parkinson's disease and related disorders.

Related Concept Videos